Tositumomab: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 19: | Line 19: | ||
! Tositumomab | ! Tositumomab | ||
! 167000 | ! 167000 | ||
! | ! 205800 | ||
! Ibritumomab | ! Ibritumomab | ||
|- | |- | ||
| Line 37: | Line 37: | ||
! 64.8 | ! 64.8 | ||
! 68 | ! 68 | ||
! | ! 206 | ||
! Ibritumomab | ! Ibritumomab | ||
|- | |- | ||
| Line 49: | Line 49: | ||
! .078 | ! .078 | ||
! .017 | ! .017 | ||
! | ! .009 | ||
! Ibritumomab | ! Ibritumomab | ||
|- | |- | ||
| Line 58: | Line 58: | ||
! Ibritumomab | ! Ibritumomab | ||
|- | |- | ||
! Dosage | ! Dosage | ||
! Tositumomab | ! Tositumomab | ||
! 500 (4th Infusion) | ! 500 mg (4th Infusion) | ||
! | ! 325 mg/m<sup>2</sup> (4th Infusion) | ||
! Ibritumomab | ! Ibritumomab | ||
|- | |- | ||
